This website uses cookies, including third party ones, to allow for analysis of how people use our website in order to improve your experience and our services. By continuing to use our website, you agree to the use of such cookies. Click here for more information on our and .
overview
Bio Connections Australia explores drug development, early phase clinical trials, translational research and expediting Australia’s great science into commercialization. It comes at a critical time for Australia’s medical research sector.
The focus of the agenda this year will be on translation and commercialization of homegrown Australian research, improving drug development and clinical trials in Australia as well as the impact of COVID-19 on the landscape.
The Federal Health Minister asserts that Australia has an opportunity to become a world leader in future medical research. Other experts have echoed the sentiment that we have a golden opportunity to attract new medical research, technology and clinical trials to Australia and added that there is also an opportunity to grow pandemic-related research and other areas. If this is true, how can we capture this opportunity? What needs to change?
Bio Connections Australia provides an important platform for further discussion and debate on what the challenges, opportunities and realities may be for drug development, clinical trials and medical research in Australia.
Themes and Topics to be discussed:
- Developing & Delivering New Medicines & Vaccines – What the Pandemic is Teaching Us About Australia’s Drug Development
- The Current and Future Clinical Trials Landscape and Australia’s Position Post COVID-19
- How do we get more Australian programs into Clinical Trials from Homegrown IP/Programs?
- Attracting Biotech Investment to Australia – Preparing an Effective Strategy for Capital Raise
- Translating Research at Unprecedented Speeds: Developing a Novel COVID-19 Vaccine in Australia
- Planning for Phase 1 Clinical Trials in Australia in the COVID-19 ERA
- ‘Virtual’ or Teletrials in Australia – Transformation and Maintaining Efficiencies with Digital Innovations
- Maintaining Momentum, Sustainable Strategies & Creating Value in Adjacencies
- Partnerships for the Future – Complimentary Ecosystems to Accelerate Drug Discovery & Development
- Digital Tools in the Connected Era for Clinical Trials
- Navigating Regulation in Australia Vs Overseas
- Taking Advantage of the R&D Tax Incentive in Australia
pricing
speakers
Mark Sullivan
2019 VIC Australian of the Year and Managing Director, Medicines Development for Global Health
Adam Houghton
VP and Head, AbbVie Ventures, Boston/Chicago
Glenn Begley
Chief Executive Officer, BioCurate Pty Ltd
Dr Anand Gautam
Executive Director & Emerging Science Lead, Emerging Science & Innovation, Asia & APAC (Australia & New Zealand), Pfizer Worldwide R&D
Mark Ashton
Executive Director, IP Commercialisation, UniQuest
Professor Sabe Sabesan
Director of Medical Oncology, Townsville Cancer Centre, Co-Chair, Australian Teletrial Consortium, Clinical Oncology Society of Australia
Associate Professor Tam C. Nguyen
Deputy Director of Research, St Vincent's Hospital Melbourne
Kathy Harrison
CEO, HAVAH Therapeutics
Professor Paul Young
Professor of Virology and Head of School, School of Chemistry and Molecular Biosciences, University of Queensland
Dr Katharine Giles
CEO & Managing Director, OncoRes Medical
Anne Woollett
Clinical Trials Director, TrialHub, Alfred Health
Associate Professor Kate Burbury
Haematologist and Disease Group Lead: Myeloproliferative Disorders/Chronic Myeloid Leukaemia, Peter MacCallum Cancer Centre
Laura Issa
Business Development, Search & Evaluation Lead, ANZ, AbbVie Pty Ltd
Kelly Constable
Venture Partner, One Ventures
Michael Molinari
MD Australia, IP Group
Kathy Nielsen
Director, Commercialisation (Life Sciences), Monash University
Bio Connections Australia Goes Virtual
The health and safety of our delegates, speakers and staff is our top priority. That is why Bio Connections will now run as a virtual event. We are delighted to present an innovative and creative format for the event which allows for greater participation from delegates both across Australia and around the world as their participation is no longer inhibited by the cost and time required for travel to Australia.
This virtual event will be hosted on a sophisticated, fully interactive platform that encourages communication through instant chat and video meetings. This event has a longer life span, having access to the excellent networking capabilities for one month after, but also access to the quality content after the event.
The content will be world class with a selection of local and international industry leaders and experts and the ability to directly ask questions and engage virtually from the safety and comfort of your own home or workplace anywhere in the world. The networking will be more productive and the business development opportunities will be measurable and impactful with a streamlined platform to promote your solution and connect with the right people.
ON DEMAND CONTENT
Gain access to live content of the conference along with quality matchmaking and Q&A opportunities! Hear from leading industry experts live and schedule your sessions with a virtual agenda, completely customizable to opt into any panels offered across the event.
QUALITY NETWORKING
With intent based and AI powered virtual matchmaking, you will meet quality leads over 1:1 meetings to make meaningful connections.
LIVE DISCUSSIONS
View and interact with other participants and speakers during the sessions with live Q&A, chats and polls.
VIRTUAL EXHIBITION
A virtual showcase of players in the industry for you to view product demos, network and take your business to the next level.
See below a quick 3-minute video that showcases how the virtual platform works:
Bio Box Australia
Bio Box Australia is a video-on-demand service providing a deeper dive on key topics, themes and questions relating to Bio Connections Australia. Bio Box will explore a wide range of topic areas including drug discovery and development, clinical trials, translating research, commercialization, going global strategies, capital raising and much more! It offers a range of perspectives from Australia and abroad.
Each Bio Box Australia episode be different with a mix of fireside chats, panels, presentations, bespoke digital theatre recordings and much more! Each month we release a new episode on a different topic.
The best part? This content is available in the lead-up to, during and after the Bio Connections Australia event each year so you can keep coming back!
Episode Schedule
Episode 1: FREE Live Digital Theatre: Re-writing the Optimised Clinical Trials Playbook
Episode 2: Understanding & Navigating the US Market
Episode 3: Regulatory Pathways in Australia Vs Abroad
Episode 4: Commercialising Clinical Trials
Episode 5: First in Human Trials – Doing it Well in Australia
Episode 6: Regenerative Medicine Opportunities in Australia
More to come!
For more information about Bio Box Australia and to enquire about featuring in one of our episodes, please contact Danielle Newman
P: +61 427 756 333
E: Danielle.Newman@informa.com
Bespoke Digital Theatre
FREE TO ATTEND! Register here
Thursday 13 August 15:00-16:00 Singapore Standard Time (SST)
Re-writing the Optimised Clinical Trials Playbook
This bespoke digital theater takes place on Thursday 13th August 15:00-16:00 Singapore Standard Time (SST).
The clinical trial environment was already evolving at a rapid pace before the presence of COVID-19, but now speed and efficiency are paramount. With a focus toward achieving faster time to market, reducing R&D costs, and increasing clinical trial success rates, various digital tools such as AI, machine learning, telemedicine are quickly becoming the next frontier in clinical studies.
Alongside the case study sharing of these digital strategies, multiple illustrative examples will be used to present the practical considerations and execution of designing and running various adaptive design strategies, including logistics and impact on clinical operations, data management, and randomization services with focus on implications for statisticians.
The Expert Panelists
Moderator
Dr. Chen Guang
Consultant and Clinical Diagnostics Technologist
Stronghold Diagnostic Lab – A*STAR, Singapore
Panelists
Dr. Harish Dave
Co-Founder and Chief Medical Officer
AUM Biosciences, Singapore
Dr. Tam C. Nguyen
Deputy Director of Research, St. Vincent’s Hospital Melbourne
Associate Professor, Melbourne Medical School
Adjunct Associate Professor, RMIT University, Australia
Dr. K. Arnold Chan
Director of Clinical Trial Center
National Taiwan University Hospital, Taiwan
The Bespoke Digital Events Series is a joint initiative of Pharmacon Asia and Bio Connections Australia.
The 7th Annual Pharmacon Asia will be delivered virtually from 23-25 September 2020.
For more information, visit the Pharmacon website.
Insights
How AUM biosciences is improving drug availability and affordability worldwide
Read more >>
Clinical trial partnerships with Australia | a US pharmaceutical firm case study
Read more >>
Is Australia your next best destination for clinical trials?
Read more >>
Clinical Trials Report Highlights Australia’s Competitive Advantages… And Weaknesses
Read more >>
Australia’s Capability in Clinical Trials
Read more >>
Status Quo or No? 2017 Completed Clinical Trials
Read more >>
contact
Still have a question?
Frankie Brewer
Conference Manager
+61 2 9080 4015
Francesca.Brewer@informa.com
Danielle Newman
Senior Business Development Manager
+61 (2) 9080 4432
Danielle.Newman@informa.com
